NDC 51808-218
Pyrophosphate
Pyrophosphate
Pyrophosphate is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Sodium Pyrophosphate.
| Product ID | 51808-218_e247d821-b132-4a87-a71a-8bc13c71fcfc |
| NDC | 51808-218 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Pyrophosphate |
| Generic Name | Pyrophosphate |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2012-05-23 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | AnazaoHealth Corporation |
| Substance Name | SODIUM PYROPHOSPHATE |
| Active Ingredient Strength | 28 mg/1 |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |